Description

A multi-peptide blend containing BPC-157, GHK-Cu, TB-500, and KPV for laboratory investigation of peptide combinations and related biological pathways. For laboratory use only; not for human or veterinary use.

Product overview

Klow combines BPC-157, GHK-Cu, TB-500 and KPV. Its component literature spans tendon-cell signaling, fibroblast and skin models, thymosin beta-4 wound models, and KPV transport and inflammatory responses in intestinal models.

These references concern individual compounds and experimental preparations. They are not trials of the finished Klow blend and do not establish synergy, human benefit or a dosing regimen. Confirm TB-500 identity and the individual component amounts from product documentation.

References

Read the original publications for methods, limitations and the preparation studied.

  1. Chang et al., 2014: BPC-157 in rat tendon fibroblasts (PMID 25415472)
  2. 2023 study: GHK-Cu with hyaluronic acid in fibroblast and skin models (PMID 37062921)
  3. Malinda et al., 1999: thymosin beta-4 in a rat wound model (PMID 10469335)
  4. Dalmasso et al., 2008: KPV uptake and intestinal inflammation (PMID 18061177)

Certificate of Analysis

Original laboratory reports for KLOW 80mg. Documents are listed by report date. Findings apply to the individual samples tested; refer to each original report for its results.

Verify this batch

Print or download (PDF)